Envoy Medical, Inc.
COCH
$0.66
$0.034.79%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.11M | -23.76M | -21.79M | -21.27M | -19.52M |
| Total Depreciation and Amortization | 314.00K | 302.00K | 270.00K | 243.00K | 200.00K |
| Total Amortization of Deferred Charges | 944.00K | 964.00K | 976.00K | 1.00M | 1.02M |
| Total Other Non-Cash Items | 1.16M | 2.45M | 2.08M | 2.79M | 728.00K |
| Change in Net Operating Assets | 159.00K | 1.84M | 857.00K | 1.34M | 1.49M |
| Cash from Operations | -20.54M | -18.20M | -17.61M | -15.90M | -16.09M |
| Capital Expenditure | -173.00K | -179.00K | 527.00K | -88.00K | -877.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -173.00K | -179.00K | 527.00K | -88.00K | -877.00K |
| Total Debt Issued | 5.00M | 10.00M | 15.00M | 22.50M | 20.00M |
| Total Debt Repaid | -902.00K | -927.00K | -949.00K | -866.00K | -892.00K |
| Issuance of Common Stock | 37.10M | 7.10M | 3.05M | 344.00K | 63.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -607.00K | -1.82M | -2.43M | -4.27M | -3.66M |
| Other Financing Activities | 66.00K | 2.28M | 1.54M | 1.82M | 1.82M |
| Cash from Financing | 40.65M | 16.63M | 16.21M | 19.53M | 17.33M |
| Foreign Exchange rate Adjustments | -4.00K | 3.00K | 1.00K | 1.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.94M | -1.74M | -869.00K | 3.54M | 366.00K |